![Stephanie Tozzo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephanie Tozzo
Chief Tech/Sci/R&D Officer at
Avilar Therapeutics, Inc.
Profile
Stephanie Tozzo currently works at Avilar Therapeutics, Inc., as Chief Science Officer & Senior Vice President from 2021.
Dr. Tozzo also formerly worked at CohBar, Inc., as Director from 2022 to 2023.
Dr. Tozzo received her graduate degree from Université Paris-Saclay.
Stephanie Tozzo active positions
| Companies | Position | Start |
|---|---|---|
Avilar Therapeutics, Inc.
 Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases | Chief Tech/Sci/R&D Officer | 2021-10-31 |
Former positions of Stephanie Tozzo
| Companies | Position | End |
|---|---|---|
| COHBAR | Director/Board Member | 2023-11-09 |
Training of Stephanie Tozzo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
CohBar, Inc.
 CohBar, Inc. BiotechnologyHealth Technology Develops biotechnology products that intends to treat age-related diseases through the discovery of novel mitochondrial-derived peptides | Health Technology |
Université Paris-Saclay
 Université Paris-Saclay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avilar Therapeutics, Inc.
Avilar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops covalent drugs to treat cancer and other autoimmune diseases | Commercial Services |
- Stock Market
- Insiders
- Stephanie Tozzo
